Captrust Financial Advisors Corcept Therapeutics Inc Transaction History
Captrust Financial Advisors
- $34.2 Billion
- Q4 2024
A detailed history of Captrust Financial Advisors transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Captrust Financial Advisors holds 113,988 shares of CORT stock, worth $6.46 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
113,988
Previous 103,740
9.88%
Holding current value
$6.46 Million
Previous $4.8 Million
19.67%
% of portfolio
0.02%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding CORT
# of Institutions
402Shares Held
84.3MCall Options Held
1.04MPut Options Held
1.33M-
Black Rock Inc. New York, NY16.5MShares$937 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$573 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$459 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$351 Million0.49% of portfolio
-
Parallel Advisors, LLC3.83MShares$217 Million4.44% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $6.07B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...